Current and remote blood pressure and cognitive decline

被引:201
作者
Glynn, RJ
Beckett, LA
Hebert, LE
Morris, MC
Scherr, PA
Evans, DA
机构
[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Prevent Med, Boston, MA 02215 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[3] Rush Univ, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA
[4] Rush Univ, Rush Inst Healthy Aging, Chicago, IL 60612 USA
[5] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
[6] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 05期
关键词
D O I
10.1001/jama.281.5.438
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Previous studies raise the possibility that blood pressure (BP) in middle age predicts later cognitive decline. Objective To examine prospectively the relationship of BP with level of and change in cognitive function in the elderly. Design Longitudinal, population-based study comprising subjects enrolled in the East Boston component of the Established Populations for the Epidemiologic Study of the Elderly (EPESE) (1982-1983) and the Hypertension Detection and Follow-Up Program (HDFP) (1973-1974). Setting East Boston, Mass. Participants Of the 3657 participants in the EPESE with baseline BP measurements, 2068 also participated in the HDFP. Subjects were aged 65 to 102 years at baseline in the EPESE and had mental status and memory assessed at baseline and 3 and 6 years. Main Outcome Measures Numbers of errors on the Short Portable Mental Status Questionnaire and the East Boston Memory Test and rates of change in these numbers of errors. Subjects had BP measured both at baseline in the EPESE and 9 years before, as part of the HDFP. Results In analyses adjusted for age, sex, and education, there was no strong linear association between BP and cognition. The associations found were fairly small in magnitude, and varied according to which test was used to measure cognition. There was little evidence for an effect of BP on change in cognitive function with either test, or for an effect on level of function on the memory test. In analyses of level of mental status questionnaire performance, however, elevated systolic BP (greater than or equal to 160 mm Hg)9 years before baseline was associated with a 14% (95% confidence interval [CI], 4%-25%) increase in error rate, relative to the referent (130-139 mm Hg). Baseline systolic BP had a U-shaped association with the number of errors; error rates were 9% higher compared with the referent group among those with systolic BP lower than 130 mm Hg (95% CI, 1%-17%) and 7% greater (95% CI, 0%-15%) among those with elevated systolic BP. Diastolic BP 9 years before baseline also had a U-shaped association with errors on the mental status questionnaire. Conclusion The findings do not suggest a linear association of BP with cognitive decline, but they are consistent with a more complex relationship between BP and cognition than previously appreciated.
引用
收藏
页码:438 / 445
页数:8
相关论文
共 35 条
  • [1] USE OF BRIEF COGNITIVE TESTS TO IDENTIFY INDIVIDUALS IN THE COMMUNITY WITH CLINICALLY DIAGNOSED ALZHEIMERS-DISEASE
    ALBERT, M
    SMITH, LA
    SCHERR, PA
    TAYLOR, JO
    EVANS, DA
    FUNKENSTEIN, HH
    [J]. INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1991, 57 (3-4) : 167 - 178
  • [2] AMERY A, 1985, LANCET, V1, P1349
  • [3] [Anonymous], 1978, J Chronic Dis, V31, P651
  • [4] [Anonymous], 1991, JAMA, V265, P3255
  • [5] CARDIOVASCULAR-DISEASE AND DISTRIBUTION OF COGNITIVE FUNCTION IN ELDERLY PEOPLE - THE ROTTERDAM STUDY
    BRETELER, MMB
    CLAUS, JJ
    GROBBEE, DE
    HOFMAN, A
    [J]. BRITISH MEDICAL JOURNAL, 1994, 308 (6944) : 1604 - 1608
  • [6] UNTREATED BLOOD-PRESSURE LEVEL IS INVERSELY RELATED TO COGNITIVE-FUNCTIONING - THE FRAMINGHAM-STUDY
    ELIAS, MF
    WOLF, PA
    DAGOSTINO, RB
    COBB, J
    WHITE, LR
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1993, 138 (06) : 353 - 364
  • [7] Evans D A, 1993, Ann Epidemiol, V3, P71
  • [8] Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
    Forette, F
    Seux, ML
    Staessen, JA
    Thijs, L
    Birkenhäger, WH
    Babarskiene, MR
    Babeanu, S
    Bossini, A
    Gil-Extremera, B
    Girerd, X
    Laks, T
    Lilov, E
    Moisseyev, V
    Tuomilehto, J
    Vanhanen, H
    Webster, J
    Yodfat, Y
    Fagard, R
    [J]. LANCET, 1998, 352 (9137) : 1347 - 1351
  • [9] Gale CR, 1996, BRIT MED J, V312, P608
  • [10] Gfeller JD, 1996, J CLIN PSYCHOL, V52, P191, DOI 10.1002/(SICI)1097-4679(199603)52:2<191::AID-JCLP10>3.0.CO